RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 84 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2014. The put-call ratio across all filers is 2.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $158,000 | -24.8% | 10,000 | -50.0% | 0.01% | -14.3% |
Q4 2014 | $210,000 | +9.4% | 20,000 | 0.0% | 0.01% | +40.0% |
Q3 2014 | $192,000 | -11.9% | 20,000 | +5.8% | 0.01% | 0.0% |
Q2 2014 | $218,000 | -41.1% | 18,900 | -48.9% | 0.01% | -28.6% |
Q1 2014 | $370,000 | +105.6% | 37,000 | +168.3% | 0.01% | +75.0% |
Q4 2013 | $180,000 | – | 13,790 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 888,132 | $7,966,000 | 6.12% |
LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 1,054,678 | $9,460,000 | 3.30% |
Kassirer Asset Management Corp | 363,700 | $3,262,000 | 2.36% |
WATER ISLAND CAPITAL LLC | 3,359,140 | $30,131,000 | 1.91% |
Banco BTG Pactual S.A. | 338,889 | $3,040,000 | 1.43% |
GARDNER LEWIS ASSET MANAGEMENT L P | 1,941,012 | $17,411,000 | 1.41% |
FIRST NEW YORK SECURITIES LLC /NY | 237,500 | $2,130,375,000 | 1.41% |
ALPINE ASSOCIATES MANAGEMENT INC. | 3,804,600 | $34,089,000 | 1.25% |
Atika Capital Management LLC | 300,000 | $2,691,000 | 1.10% |
Atika Capital Management LLC | 298,200 | $2,672,000 | 1.09% |